Skip to content
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
  • български
Shopping Cart 0
Facebook
GPNews
  • Home
  • IssuesExpand
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summariesExpand
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
Shopping Cart 0
Facebook

  • български

GPNews
Home / Ophtalmology / Efficacy of the PreseFlo MicroShunt in patients with open-angle glaucoma: a retrospective study

Efficacy of the PreseFlo MicroShunt in patients with open-angle glaucoma: a retrospective study

отGP News публикувано на 29.07.2024 Ophtalmology
пациенти с откритоъгълна глаукома

Issue 7/2024

Daskalov, V., Kermedchieva, R.
SOBAL «Pentagram» – Sofia

Objective: The aim of the present study was to present the efficacy of the PreserFlo MicroShunt (Santen, Osaka, Japan) after surgical treatment in patients with open-angle glaucoma.
Material and Methods: A retrospective analysis of patients with open-angle glaucoma after microinvasive glaucoma surgery (MIBS) with PreserFlo implantation with MMC 0.4 mg/mL administered over 2 min intraoperatively was performed. A total of 43 patients (50 eyes) were included, of which 22 men (%) and 21 women (%). The average age is 65.26 years (32 – 91 years). The implantations were carried out in the period 2020-2023. with a follow-up period of two years. Before surgery, all patients had uncompensated IOP on hypotensive therapy. IOP values ​​<= 18mm/Hg without or with additional drug therapy were accepted as successful surgery and function. The operative interventions of all patients were performed by one surgeon at SOBAL “Pentagram”. Results: After the performed procedure, we reported the effectiveness of the PreserFlo microimplant in reducing IOP, with 82% of the values ​​being

Post navigation

Previous Previous
Clinical study in Plateau Iris Configuration and Glaucoma
NextContinue
Evolution in the classification and diagnostic methods Of retinopathy of prematurity
Search
корица 12
All issues in 2023

Issue 12/2023

PULMONOLOGY Current guidelines for the diagnosis and treatment of COPD Yordanov, P., Dimitrova, V. The point of bronchial hyperreactivity (BHR)…

Корица - 112023
All issues in 2023

Issue 11/2023

Ear / Nose / Throat Allergic rhinitis – a risk factor for asthma Perenovska, P. Phenotypes of non allergic rhinitis…

корица 10
All issues in 2023

Issue 10/2023

Endocrinology Carcinogenic risk in obesity and diabetes mellitus Karamfilova, V., Nedeva, I. Anthropometric studies on the effect of yogurt fermented…

fb like

About us

GPNews magazine
A peer of the GP practice in our country
The only specialized edition for general practitioners
12 monthly booklets on topics vital to your practice

Menu

  • Home
  • About us
  • Contact us

Information

  • For authors
  • Publishing ethics
  • For advertising

Copyright © 2025 GPNews. All rights reserved.

Web design and SEO by Tribest

  • GDPR
Scroll to top
  • Home
  • Issues
    • 2025
    • 2024
    • 2023
    • 2022
  • Article summaries
    • AG and Neonatology
    • Allergology
    • Dental Health
    • Cardiology
    • Dermatology and Cosmetics
    • Endocrinology
    • From the Practice
    • Gastroenterology
    • History Teaches
    • In the World of Viruses
    • Nature Teaches
    • Neurology and Psychiatry
    • Nutrition, Dietetics, Metabolism
    • Oncology
    • Ophtalmology
    • Others
    • Otorhinolaryngology and Pulmonary Diseases
    • Pediatrics
    • Rheumatology and Diseases of the Joints
    • Test on a Clinical Case
    • Urology and Nephrology
  • Subscription
  • About us
  • For advertising
  • For authors
  • Publishing ethics
  • Contacts
  • GDPR
Search